Galapagos Nv (GLPG)

Operator: Good day! And thank you for standing by. Welcome to the Galapagos First Quarter 2025 Financial Results and Business Update. At this time all participants are in a listener-only mode.

Wall Street has come down crashing on President Donald Trump’s sweeping tariffs, raising the risk of a trade war that could push the global economy into recession.

Biotechnology stocks are among the most volatile in the market due to their high risk.

Operator: Good day, and thank you for standing by. Welcome to the Galapagos Q3 2024 Financial Results Audio Webcast. At this time, all participants are in a listen-only mode.

Operator: Good day and thank you for standing by. Welcome to the Galapagos First Half 2024 Financial Results Conference Call. At this time, all participants are in listen-only mode.

Sofie Van Gijsel: Welcome all to the audio webcast of Galapagos' Q1 2024 Results. I'm Sofie Van Gijsel, Investor Relations representing the reporting team at Galapagos.

In this article, we will be taking a look at 11 oversold biotech stocks to buy right now.

Galapagos NV beats earnings expectations. Reported EPS is $2.39, expectations were $-2.23.

Operator: Good day, and thank you for standing by. Welcome to the Galapagos Q3 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.